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Background: A eukaryotic expression plasmid encoding glycoprotein C (gC) of Anatid herpesvirus 1 (AnHV-1)
(pcDNA3.1-gC) was constructed and validated. The tissue distribution of chitosan/DNA complexes, liposome/DNA
complexes and pcDNA3.1-gC alone were evaluated using a quantitative real-time PCR based TaqMan™ probe
following intramuscular administration in ducklings.
Results: Compared with pcDNA3.1-gC alone, liposomes universally increased the plasmid DNA copy number at the
injection sites, liver, spleen, heart, brain, bursa of Fabricius, and especially in the enteron (esophagus, duodenum,
rectum, and cecum). Chitosan also universally increased the plasmid DNA copy number at the injection sites,
liver, spleen, heart, brain and esophagus. Compared with lipoplex-gC, higher chitosan-gC plasmid DNA copy numbers
were detected at the injection sites, liver, spleen, heart, brain and esophagus. In contrast, compared with lipoplex-gC,
lower copy numbers of chitosan-gC plasmid DNA were detected in the duodenum, rectum and cecum.
Conclusions: The results of this study demonstrated that chitosan and liposomes mediated rapid and extensive
plasmid distribution in duck tissues, with low levels maintained from 1 d after DNA vaccination.
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Anatid herpesvirus 1 (AnHV-1), belonging to the family
Herpesviridae, subfamily Alphaherpesvirinae, genus
Mardivirus, is the cause of severe epidemics of duck
virus enteritis (DVE), which account for significant
economic losses. DVE, also referred to as duck plague, is
a highly contagious acute disease of ducks, geese, and
swans, which is characterized by hemorrhagic lesions in
the blood vessels, gastrointestinal mucosa, and lymphoid
tissues [1-3].
As a multifunctional glycoprotein of Alphaherpesvirinae,
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reproduction in any medium, provided the orvirulence and other functions [4-15]. Good immune
responses and protective efficacy against herpesviruses
have been reported in mice and related animals following
immunization with DNA vaccines based on the gC gene
[16-19]. Our previous study also demonstrated that the
AnHV-1 gC protein was highly immunogenic [20].
DNA vaccines, which are a new generation in the vaccine
family, are defined by the expression of the exogenous
genes in vivo through a delivery system, such as naked
plasmid DNA (pDNA) [21]. However, transgene expression
occurs only in transduced cells. Therefore, the tissue
distribution of genes is an important factor determining
the efficacy of in vivo gene transfer.
Generally speaking, the tissue distribution characteristic
of an externally administered compound is determined by
its interaction with the recipient, and such interaction is
regulated by the physicochemical and biological properties. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
ab
Figure 1 Identification of the recombinant plasmid pcDNA3.1-
gC a) Schematic representation of pcDNA3.1-gC. The gC gene was
inserted into pcDNA3.1 utilizing EcoR I and Xho I sites. b) The
digestion products were separated by electrophoresis. Lane 1,
pcDNA3.1-gC; Lane 2, single fragment after restriction enzyme
digestion with EcoR I; Lane 3, single fragment after restriction
enzyme digestion with Xho I; Lane M, DNA marker-DL15000; Lane 4
two fragments after restriction enzyme digestion with Xho I and EcoR I.
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properties of the host. To improve the delivery and cellu-
lar uptake of plasmid DNA after in vivo administration, a
number of synthetic pDNA delivery vehicles have been
developed. These vehicles can currently be divided into
cationic polymers and liposomal formulations. Cationic
polymers include DNA adsorbed to or entrapped within
biodegradable materials such as poly-lactide-co-glycolide
or chitosan. Both cationic polymers and liposomal formu-
lations make use of the electrostatic interaction between
negatively charged nucleic acids and the positive charges
of the synthetic vector [22].
In our research, we developed a novel delivery system,
designated pcDNA3.1-gC. A clear understanding of the
tissue distribution of pcDNA3.1-gC and its complexes
formed with synthetic carrier systems is a prerequisite
for a strategy aimed at developing effective in vivo gene
transfer methods. Here, we discuss the tissue distribution
characteristics of pcDNA3.1-gC, which was systemically
administered in the free and complexed forms.
Results
Construction and identification of pcDNA3.1-gC
As shown in Figure 1a, AnHV-1 gC gene was cloned
into the eukaryotic expression vector pcDNA3.1(+),
resulting in the DNA vaccine plasmid pcDNA3.1-gC.
DNA sequencing showed that pcDNA3.1-gC was correct.
The constructed plasmid was subjected to digestion with
EcoR I and Xho I. Electrophoretic separation of the diges-
tion products (Figure 1b) showed that the construction of
the recombinant plasmid was successful.
Expression of pcDNA3.1-gC in eukaryotic cells
As shown in Figure 2, intensive fluorescence was found in
the cytoplasm of COS-7 cells transfected pcDNA3.1-gC
following staining with polyclonal anti-gC hyperimmune
serum. In contrast, no fluorescence was detected in COS-7
cells transfected with pcDNA3.1(+).
Biodistribution of pcDNA3.1-gC alone
The biodistribution of pcDNA3.1-gC in duckling tissues
was determined following intramuscular injection. Copy
numbers were quantified in different organs at various
times after intramuscular injection. As shown in Figure 3,
differences in plasmid distribution were observed be-
tween organs. One hour post-injection, plasmid DNA
was widely distributed among all the analyzed organs.
The concentration of plasmid DNA was determined in
order of the injection site (liver, kidney, lung, heart,
cecum and spleen) at 1 h post-injection. However, at the
highest levels, the concentrations of plasmid DNA in
other tissues were 1–2 orders of magnitude lower than
at the injection site. Plasmid DNA was detected in all
analyzed organs from 1 h to 10 weeks post-injection. Atthe injection site, there was a 3.7 × 103-fold reduction in
the plasmid copy numbers at 1 d compared with 1 h
post-injection. In other organs, there was also a significant
decrease at 1 d compared with 1 h post-injection.
Subsequently, the number of plasmid copies was
maintained at a low level. However, higher plasmid
copy numbers (approximately 10-fold) were detected
at the injection site than in other organs at different








Figure 2 Distribution of pcDNA3.1-gC in COS-7 cells by indirect immunofluorescence assay.
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the blood-brain barrier.
Biodistribution of lipoplex-gC
As shown in Figure 4, plasmid DNA was detected in all
analyzed organs from 1 h to 10 weeks post-inoculation.
One hour after intramuscular administration, plasmid
DNA was distributed widely in all analyzed organs. The
highest plasmid DNA concentration was detected at the
injection site, cecum, and liver at 1 h. Similar to
pcDNA3.1-gC alone, at the highest levels, the concentra-
tions of plasmid DNA in other tissues were still 2–3 orders
of magnitude lower than those at the injection site, and the
number of plasmid copies was maintained at a low level
after 1 d, with minimum copy numbers detected in the
brain. However, compared with pcDNA3.1-gC alone, lipids






















Figure 3 Biodistribution of pcDNA3.1-gC in ducklings immunized wit
copies per microgram DNA obtained from two ducklings.organs, especially in the enteron (esophagus, duodenum,
rectum, and cecum).
Biodistribution of chitosan-gC
As shown in Figure 5, similar to pcDNA3.1-gC alone
and lipoplex, chitosan-gC complexes also showed the
highest organ distribution at the administration site.
One hour after intramuscular administration, plasmid
DNA was widely distributed in all analyzed organs. The
plasmid copy numbers detected at 1 d were substantially
lower than those detected at 1 h post-inoculation. In
parenchymatous organs, the chitosan/DNA complex
group exhibited higher plasmid DNA levels than those
detected in the other groups. A notable difference in
plasmid DNA levels was detected in the brain, with 39-fold
higher levels in the chitosan/DNA group compared with














h pcDNA3.1-gC alone. Each time point represents the mean plasmid



































Figure 4 Biodistribution of pcDNA3.1-gC in ducklings immunized with lipoplex-gC. Each time point represents the mean plasmid copies
per microgram DNA obtained from two ducklings.
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DNA immunization against AnHV-1 has been developed
in our laboratory [20]. To increase the efficacy of the
AnHV-1 gC DNA vaccine, DNA-lipid complexes and
chitosan-DNA nanoparticles were prepared. In the present
study, the fates of these complexes and pcDNA3.1-gC alone
following intramuscular injection were investigated in
ducklings. To our knowledge, this study is the first
assessment of the organ distribution and retention
time of plasmid DNA administered in lipid complexes






















Figure 5 Biodistribution of pcDNA3.1-gC in ducklings immunized wit
per microgram DNA obtained from two ducklings.More than three decades ago, Wolff showed that the
injection of mouse muscle with a DNA plasmid resulted
in significant expression of the protein encoded by the
plasmid [21]. Progress in the field of DNA vaccination
has resulted in the development and the marketing of
three veterinary DNA vaccines [23]. The uptake of DNA
plasmid by cells upon injection is very inefficient: only a
small proportion of the injected material is internalized
by cells and results in successful transfection [24].
Therefore, a number of strategies have been used for














h chitosan-gC. Each time point represents the mean plasmid copies
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and cationic polymers, both of which have shown promise
for enhancing the expression and immunogenicity of
plasmid DNA vaccines in animal models [25].
Our results showed that liposomes universally increased
the plasmid DNA copy numbers at the injection site, liver,
spleen, heart, brain, bursa of Fabricius, and especially in
the enteron (esophagus, duodenum, rectum, and cecum),
compared with pcDNA3.1-gC alone. Similarly, chitosan
also universally increased the plasmid DNA copy numbers
at the injection site, liver, spleen, heart, brain and esopha-
gus. These results indicated that liposomes and chitosan
enhance the distribution in tissues. In addition, compared
with lipoplex-gC, chitosan-gC mediated production of
higher numbers of plasmid DNA copies at the injection
site, liver, spleen, heart, brain and esophagus. Nevertheless,
compared to lipolex-gC, lower copy numbers were detected
in duodenum, rectum, and cecum.
In terms of the effects of time after inoculation, the
highest concentrations of DNA were detected all the
tissues at 1 h after injection. The number of plasmid copies
had decreased by 3–4 orders of magnitude at 1 day after
injection. Subsequently, the number of plasmid copies was
maintained at a low level and plasmid DNA was still be
detected 10 weeks post-injection. Our study is consistent
with other studies, which have shown that plasmid
remained for several weeks following clearance of the
majority of the plasmid within the first 24 h post-
inoculation [26-28]. Additionally, results based on indirect
immunohistochemical staining (IHC) have shown that the
gC proteins are still found in the liver, bursa of Fabricius,
duodenum, caecum and rectum in the intramuscular
injection group at 10 weeks post-inoculation [29].
Transfection of cells by chitosan nanoparticles and
lipoplexes occurs in three phases: (1) cellular uptake by
formation of endosomes into the target cells; (2) release
from the endosome; (3) entry of plasmid DNA into the
cell nucleus [30,31]. Liposomes can protect the nucleic
acid from extracellular degradation, ensuring appropriate
tissue targeting, and facilitating the delivery of functional
DNA into the cell [32,33]. As a cationic polymers,
chitosan (CS) is an effective, naturally-occurring material
used for synthesizing nanoparticles with advantageous
properties such as low toxicity, low immunogenicity and
excellent biocompatibility [34,35]. Accordingly, following
inoculation with chitosan/DNA or liposome/DNA
complexes, plasmid DNA diffuses from the injection site
and/or degrades more slowly because of a liposomes or
chitosan depot effect. The liposome/DNA or chitosan/
DNA depot is thought to provide some protection
against nucleases, thus extending the half-life of the
plasmid DNA at the injection site [30]. It has been
shown that formulation of DNA vaccines into liposomes
enhances cellular and humoral immunity [34,35]. Ourprevious study also showed that chitosan significantly
improved CD4+ and CD8+ T cell responses to at least
6 weeks post-injection in Balb/c mice [36]. The im-
mune responses to these formulations and protection
against Anatid herpesvirus 1 challenge in ducks are
currently being analyzed.
Fluorescence-based quantitative real-time PCR (qPCR)
is commonly regarded as a straightforward, mature and
ubiquitous means of molecular biology [37]. Probe-based
qPCR technology is recommended as the reference tech-
nique for monitoring gene transfer biodistribution [38].
Therefore, in our previous study, we established a qPCR
protocol based on the use of a TaqMan™ probe [39]. In
contrast to previous studies, equivalent amounts of DNA
(100 μg) were injected in the form of pcDNA3.1-gC,
DNA-lipid complexes and chitosan-DNA nanoparticles
and 200 ng of gDNA were used in each PCR reaction by
preparation of the appropriate dilution ratios. Because we
observed that there existed the inhibition due to the
gDNA matrix, which affected quantification using
qPCR (data not shown). This was consistent with other
studies [40]. In the present study, 100 μg of plasmid
was injected for each group. The same amount of each
tissue was collected.
In summary, we successfully used chitosan and lipid
formulations for DNA vaccination in ducklings. Compared
with pcDNA3.1-gC alone, chitosan/DNA and DNA/lipid
complexes improved the efficiency of plasmid distribution.
The complexes were rapidly absorbed, and extensive and
relatively long-term distribution at low concentrations was
observed following DNA vaccination in ducklings.
Conclusions
In this study, we succeeded in constructing a eukaryotic
expression plasmid encoding the AnHV-1 gC gene.
Endonuclease digestion and indirect immunofluorescence
confirmed the identity of the construct and quantitative
real-time PCR analysis demonstrated rapid and extensive
distribution of the plasmid, which was subsequently
maintained at a low level after one day. Thus, chitosan and
lipid mediate efficient plasmid distribution and facilitate
long-term maintenance of the plasmid.
Methods
Plasmid preparation
As shown in Figure 1a, pcDNA3.1-gC, which encoded
the AnHV-1glycoprotein C, was generated by cloning
gC gene into the EcoR I and Xho I sites of pcDNA3.1(+)
(Invitrogen, USA) vector according to the manufacturer’s
protocol. The purified gC gene was obtained from
pMD18-gC [41] by restriction enzyme digestion (EcoR I
and Xho I) (Takara, Japan). The pcDNA3.1-gC plasmid
was transformed into E. coli JM109. By means of a fed-
batch process for high cell density cultivation, E. coli
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Cplus fermenter (Sartorius, Germany). The fermentation
broth was centrifuged at 5000 × g for 10 min in an
Avanti J-26XP Centrifuge (Beckman Coulter, USA).
Preparation and purification of plasmid DNA were
based on alkaline lysis with SDS (maxipreparation) and
precipitation with polyethylene glycol as described by
Sambrook [42]. The purity of plasmid DNA was
assessed by agarose gel electrophoresis and using the
260 nm and 280 nm absorbance ratio (A260/280). The
purified DNA was stored at −20°C.
Transient expression and indirect immunofluorescence
(IIF) assay
The pcDNA3.1-gC was first transfected into COS-7 cells
using Lipofectamine™ 2000 (Invitrogen, USA) according
to the manufacturer’s instructions. Briefly, plasmid DNA
(4 μg) was diluted with 250 μL serum-free DMEM media.
Lipofectamine (10 μL) was diluted with the same media.
The diluted plasmid DNA and Lipofectamine solutions
were then mixed. The DNA-Lipofectamine solutions were
added to six-well culture plates containing coverslips.
After incubation at 37°C for 48 h, cells were fixed with 4%
paraformaldehyde. After blocking for 1 h in phosphate-
buffered saline (PBS) containing 10% BSA at 37°C, the
coverslip was incubated with the anti-gC IgG anti-
bodies (1:100) at 4°C overnight, and then treated with
FITC-conjugated goat anti-rabbit IgG (Sino-American
Biotechnology Co., China) (1:100) for 45 min at 37°C.
The stained cells were examined with the Nikon 80i
fluorescence microscope (Tokyo, Japan).
Preparation of DNA-lipid complexes (designated lipoplex-gC)
DNA-lipid complexes were prepared as described by
Rosada [43] and Torchilin [44]. The required amounts
of all lipid stock solutions in chloroform (PC/CH/ODA
5:4:1 molar) were mixed and dried to a thin film using a
rotary evaporator in vacuum for 1 h. The films were
hydrated in sterile water above its phase transition
temperature. The hydrated lipid solution was then soni-
cated and passed sequentially through two polycarbonate
membranes (0.45 μm nominal diameter and 0.22 μm
nominal diameter; 15 times per membrane). DNA
(pcDNA3.1-gC) was mixed with the extruded liposomes
at a lipid/DNA mass ratio of 1/50, frozen, and vacuum
freeze-dried overnight. Controlled rehydration of the dry
powders with PBS resulted in the formation of liposomes
encapsulating the DNA.
Preparation of chitosan-DNA nanoparticles (designated
chitosan-gC polyplexes)
Chitosan (MW 55 kDa, deacetylation degree 90%, medical
grade) was kindly provided by Golden-Shell Biochemical
Co., Ltd (China). It was purified by reprecipitation fromthe filtered 1% acetic acid solution with ammonium
hydroxide. The precipitate was washed with water and
dried under vacuum. The purified chitosan was dissolved
in 1% acetic acid with gentle heating and the pH of the
solution was adjusted to 5.5–5.7 with sodium hydroxide.
The solution was diluted to 0.03% chitosan (w/v) and
5 mM acetate. The pH of the chitosan stock solution was
readjusted to pH5.5 and sterile filtered through a 0.22 μm
filter. The solution was stored at 4°C. A chitosan solution
(0.03% in 5 mmol/L sodium acetate buffer, pH 5.5) and a
DNA solution (100 μg/mL in 10 mmol/L sodium sulfate
solution) were preheated to 55°C separately. An equal
volume of both solutions were quickly mixed together and
vortexed for 15–30 s (amino group to phosphate group
ratio (N/P ratio) of 3:1). The final volume of the mixture
in each preparation was limited to a maximum of 500 μL
in order to yield uniform nanoparticles. The homogeneity
of chitosan-gC polyplex nanoparticles was analyzed by
transmission electron microscopy (Hitachi H-600, Tokyo,
Japan) as described by Jiang [45].
Animal vaccination and sample collection
This study was conducted with 80 AnHV-1-free Peking
ducks (28 days old) from an AnHV-1-free farm. The
AnHV-1 status was confirmed by qualitative PCR as
described by Song [46]. The ducks were fed with
commercial duck pellets. Water troughs that were deep
enough for the ducks to float and splash were placed in
each room. Each room also had a partially enclosed dry
retreat with wood shavings for the ducks to sit on. The
ducklings were randomly divided into four equal groups
in this study. Using 5 mL syringes, ducks in groups 1–3
were inoculated by the intramuscular route with
pcDNA3.1-gC alone, lipoplex-gC, and chitosan-gC polyplex
each containing equivalent amounts of plasmid DNA
(100 μg). Ducks in group 4 were inoculated with pcDNA-
3.1(+) as a control. At each of eight sampling times, two
vaccinated ducks per group were chosen randomly for
sampling. The liver, spleen, kidney, lung, trachea,
esophagus, heart, brain, duodenum, rectum, cecum,
injection site and bursa of Fabricius were collected at
1 h, 4 h, 8 h, 12 h, 1 d, 7 d, 4 weeks and 10 weeks post-
inoculation. Each solid tissue sample was transferred to
a labeled bag, snap-frozen in liquid nitrogen, and stored
at −80°C. All animal work was conducted with the
approval of the Sichuan Agricultural University Animal
Ethics Committee.
DNA extraction from tissues
Total DNA was isolated from each of the harvested
tissues by phenol-chloroform extraction [47]. Tissue
(50 mg) was minced and suspended in 500 μL proteinase
digestion buffer (10 mmol/L Tris-HCl, 0.1 mol/L EDTA,
0.5% SDS, 20 μg/mL RNase A, pH 8.0) and
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Germany). After incubation at 37°C for 1 h, homoge-
nized tissue was digested with proteinase K (100 μg/mL)
overnight at 55°C, extracted three times with equal vol-
umes of buffered phenol and chloroform and precipitated
with 2.5 volumes of ethanol. DNA was pelleted by centri-
fugation at 13,000 × g for 10 min, rinsed in 70% ethanol
and air dried under an isolation hood before being
resuspending in 50 μL TE buffer (pH 8.0). DNA concen-
trations were determined by UV absorption at 260 nm.
The A260/280 absorbance ratio for each sample was con-
firmed to be ≥1.8. Each sample was analyzed by electro-
phoresis in a 0.8% agarose gel to ensure that the DNA
migrated predominantly as a high molecular weight
band and exhibited no detectable RNA contamination.
The tissue DNA was stored at −20°C for further
analysis.
Quantitative real-time PCR assays
The levels of gC in negative and positive control DNA
(from non-injected or pcDNA3.1-gC), and test sample
DNA were quantified by a qPCR assay as described
previously [39]. The primers used for PCR amplification
were forward primer (FP), 50-GAAGGACGGAATGGTGG
AAG-30, and reverse primer (RP), 50-AGCGGGTAACGAG
ATCTAATATTGA-30, which amplify a 78 bp fragment of
the AnHV-1 gC gene (GenBank; Accession No.: EU076811).
A 23-bp TaqMan probe (FAM-CCAATGCATCGATCATC
CCGGAA-TAMRA) complementary to an internal region
between the two primers was selected and synthesized with
a FAM (6-carboxyfluorescein) reporter molecule at the
50end and a TAMRA (tetra-methylcarboxyrhodamine)
quencher molecule at the 30end. The qPCR reactions were
carried out using a Premix Ex Taq™ kit (Takara, Japan) with
an iCycler iQ™ Multicolor Real-Time PCR Detection
System (Bio-Rad, USA). All qPCR assays were performed
using the same format. The amplification was performed in
a 20 μL reaction mixture containing 2.0 μL DNA solution
(200 ng of tissue DNA was used by preparing different dilu-
tion ratios), 10 μL 2 × Premix Ex Taq™, 0.5 μmol/L each
primer and 0.25 μmol/L fluorogenic probe. The two-step
PCR cycling conditions were as follows: initial de-
naturation and hot-start Taq DNA polymerase activa-
tion at 95°C for 5 min, 45 cycles of denaturation at
94°C for 5 s, primer annealing and extension at 53°C
for 30 s with fluorescence acquisition during each
annealing and extension stage. The tests were carried
out by using the 0.2 mL PCR tubes (Axygen, USA).
The reaction, data acquisition, and analysis were
performed using iCycler iQ™ Optical detection system
software (Version 3.1). A plasmid DNA sample was
diluted to contain 1 × 101–1 × 108 copies per test tube
and used as a standard series.Competing interests
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